Wesbanco Bank Inc Organon & Co. Transaction History

Wesbanco Bank Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Dec 11, 2023	BUY	$16.59 - $23.77 $640,091 - $917,117	38,583 Added 143.39%	65,490 $1.14 Million
Q2 2023 Jul 13, 2023	BUY	$19.27 - $24.63 $314,390 - $401,838	16,315 Added 154.03%	26,907 $561,000
Q1 2023 Apr 21, 2023	SELL	$21.42 - $32.08 $9,317 - $13,954	-435 Reduced 3.94%	10,592 $249,000
Q4 2022 Jan 18, 2023	BUY	$23.31 - $28.61 $257,039 - $315,482	11,027 New	11,027 $307,000
Q2 2022 Jul 18, 2022	SELL	$31.66 - $38.9 $84,753 - $104,135	-2,677 Reduced 16.76%	13,291 $448,000
Q1 2022 Apr 25, 2022	SELL	$30.45 - $39.36 $44,274 - $57,229	-1,454 Reduced 8.35%	15,968 $558,000
Q4 2021 Feb 02, 2022	SELL	$28.67 - $37.13 $44,811 - $58,034	-1,563 Reduced 8.23%	17,422 $531,000
Q3 2021 Oct 12, 2021	SELL	$28.63 - $35.64 $329,760 - $410,501	-11,518 Reduced 37.76%	18,985 $623,000
Q2 2021 Aug 09, 2021	BUY	$28.45 - $38.0 $867,810 - $1.16 Million	30,503 New	30,503 $922,000

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.76B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Wesbanco Bank Inc, based on Form 13F filings with the SEC.

Stay updated on Wesbanco Bank Inc with notifications on news.